The increasing incidence of infectious diseases and the rise in the geriatric population is expected to drive the market for Immunoassay Analyzers.

New York, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The Global Immunoassay Analyzers market is forecast to reach USD 26.40 Billion by 2027, according to a new report by Reports and Data. Immunoassay analyzers are primarily used to monitor transfusion medicine as in blood transfusion and organ transplant, which is likely to increase its demand. Few clinical immunoanalyzers employ automated analyzer to reduce manual intervention and chances of error as well as improve the workflow.

The increasing adoption of the immunoassay analyzer will boost the growth of the market. There is a rising prevalence of chronic and infectious diseases around the globe, requesting the need for early diagnosis. The growing demand for diagnostics is expected to be the key driving factor of the immunoassay analyzer market growth. Development in the sectors of genomics and proteomics has made the database of biomarkers expand by each day. The discovery and growing research and development activities for biomarkers of various diseases have led researchers and experts to use this knowledge to create new assays for diagnostics. Rising investments in R&D to develop new tests for the diagnosis of the diseases will promote the growth of the industry during the forecast period.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/3467

North America dominates the market owing to the increasing number of manufacturers, the spread of infectious diseases, improved healthcare infrastructure, and the development of various new products. Increasing the production of innovative products and the growth of manufacturers in Europe has fortified the region's presence in the global industry supported by major strategic initiatives.

COVID-19 Impact Analysis:

The market will witness a huge surge as biopharmaceutical innovators are in the front line for the human response to the global COVID-19 pandemic. A significant number of biotech firms are in the middle of the race to investigate the virus's genome and are preparing a viable vaccine. These companies are investigating the virus at an unprecedented rate, and considerable funds are being put into the research. The companies are in trial, and the public and private sectors are working continuously for the development of the vaccine. There is a huge demand for testing kits for the diagnosis of SARS-CoV-2, which will foster the demand for the market.

Further key findings from the report suggest

• The Enzyme-Linked Immunoassay (EIA) is used to commonly measure antigens, antibodies, glycoproteins, and proteins in biological samples. For instance, HIV infection diagnosis, measurement of cytokines, and pregnancy tests. The segment is forecasted to grow with a CAGR of 5.2% during the forecast period.
• Cancer/tumor profiling deploys a tumor-specific patient-focused approach for the treatment of cancer by precisely targeting the tumor of an individual patent. Predominantly, tumor profiling may help increase the chances of a patient benefitting from prescribed therapies for disease treatment.
• The market in the Asia Pacific region is expected to grow at the fastest rate of 5.9% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.
• Key participants include bioMerieux. Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Roche Diagnostics, Beckman Coulter, Inc., Diasorin S.p.A., Siemens Healthcare GmbH, Sigma Aldrich. Co. LLC., and Boditech Med, Inc, among others.

BUY NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/3467

For the purpose of this report, Reports and Data has segmented the Global Immunoassay Analyzers Market on the basis of product, application, end-user, and region:

• Product Outlook (Revenue, USD Billion; 2017-2027)
• Immunofluorescence analyzers
• Enzyme-Linked Immunoassay (EIA)
• Chemiluminescence Immunoassay
• Radioimmunoassay
• Consumables & Accessories
• Application Outlook (Revenue, USD Billion; 2017-2027)
• Oncology
• Therapeutic Drug Monitoring
• Endocrinology
• Cardiology
• Infectious Disease Testing
• Autoimmune Disease
• Others
• End-User Outlook (Revenue, USD Billion; 2017-2027)
• Hospitals
• Diagnostic Laboratories
• Research Institutes

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/immunoassay-analyzers-market

• Regional Outlook (Revenue, USD Billion; 2017-2027)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Benelux
• Rest of Europe
• Asia Pacific
• China
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Take a Look at our Related Reports:

Bioprosthetics Market: The increasing prevalence of rheumatoid heart disease, coronary and peripheral artery diseases, and other cardiovascular diseases have led to the increasing demand for long-term treatment and relief, factors that are anticipated to drive bioprosthetics market growth.

Stone Treatment Devices Market: Factors such as mounting geriatric populace, an expansion in the frequencies of stone formation, upsurge in the recurrence of the stone after a medical procedure, a tendency towards minimally invasive procedures are expected to propel the industry in the coming years.

Automated Insulin Delivery Systems Market: Automated Insulin Delivery Systems is an user friendly technology that regulate blood glucose level with the help of continuous glucose monitoring.

Cerebrospinal Fluid (CSF) Management Market: The unique nature of cerebrospinal fluid dynamics in each patient has challenged neurologists, neurosurgeons, and medical device developers. This has led to cumulative demand for advanced cerebral spinal fluid (CSF) management devices.

Sacral Neuromodulation Market: A rise in the prevalence of overactive bladder & urge continence among masses along with the expansion of the geriatric population base across the globe is the key factor driving the market growth.

Central Venous Catheters Market: Catheters are an efficient delivery mechanism for surgical procedures. These are medical devices, which are used for the treatment of a large number of cardiovascular diseases and other chronic disorders.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkdIn | Twitter | Blogs

Contact Us:

John Watson

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkdIn | Twitter | Blogs

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.